Active

XR THERAPEUTICS LIMITED Financials

Company number
12518684Copy
Copy
Registered office
Room 1.11, Northern Design Centre, Abbott's Hill, Gateshead, Tyne & Wear NE8 3DF
Incorporated
16/03/2020

Company snapshot

Status
Active
Employees
21 (2026)
Latest financial data
2026
Accounts type
Total Exemption Full

Financial highlights

Latest reported figures. Okredo holds filed data for 2022–2026.

Net Assets

£52.30K2026
-90.12%vs 2025

2025: £529.15K

Total Assets

£310.91K2026
-48.79%vs 2025

2025: £607.11K

Cash in Bank

£58.24K2026
-83.98%vs 2025

2025: £363.65K

Total Liabilities

£240.93K2026
378.69%vs 2025

2025: £50.33K

Employees

212026
+3vs 2025

2025: 18

In 2026, XR THERAPEUTICS LIMITED reported net assets of £52.30K. The same filing shows total assets of £310.91K, cash in bank of £58.24K and total liabilities of £240.93K. Reported headcount was 21 in 2026. Net Assets fell from £529.15K in 2025 to £52.30K in 2026 (-90.12%). Okredo holds filed figures for 2022–2026; the table below lists every reported indicator by year. See every reported indicator by year.

Financial performance

Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.

Net Assets

£52.30K2026
-90.12%from £529.15K in 2025

Year-on-year change

Net Assets as filed for 2022–2026. Every figure in this chart is also in the financial history table.

3-year financial trend (2024–2026)

How the figures XR THERAPEUTICS LIMITED filed moved across the three reported years 2024, 2025 and 2026 — measured end to end rather than year on year.

Net Assets

£845.39K2024£52.30K2026
-93.8%vs 2024

-75.1% a year compound (CAGR)

Cash in Bank

£880.41K2024£58.24K2026
-93.4%vs 2024

-74.3% a year compound (CAGR)

Total Assets

£1.32M2024£310.91K2026
-76.4%vs 2024

-51.5% a year compound (CAGR)

Total Liabilities

£440.54K2024£240.93K2026
-45.3%vs 2024

-26% a year compound (CAGR)

Employees

112024212026
+90.9%vs 2024+10

Biggest increase

Employees+90.9%

11 in 2024 to 21 in 2026

Biggest decrease

Net Assets-93.8%

£845.39K in 2024 to £52.30K in 2026

XR THERAPEUTICS LIMITED's filings pull in both directions between 2024 and 2026. The steepest rise came in employee numbers, pointing to an expanding team, set against a fall in net assets, pointing to a weakening balance sheet. See the full year-by-year figures.

Ratios from the filed figures

Calculated from XR THERAPEUTICS LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.

Net assets to total assets
16.82%2026
Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
Liabilities to total assets
77.49%2026
Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
Cash to liabilities
24.17%2026
Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
Cash to total assets
18.73%2026
Reported cash in bank divided by reported total assets, for the latest year both were filed.

Financial history

Every indicator Okredo tracks, year by year.

Reported financial indicators for XR THERAPEUTICS LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.

Indicator20222023202420252026
Net Assets£185.20K180.84K845.39K529.15K52.30K
Total Assets£211.98K270.38K1.32M607.11K310.91K
Cash in Bank£–17.21K880.41K363.65K58.24K
Total Liabilities£26.79K57.96K440.54K50.33K240.93K
Employees99111821

XR THERAPEUTICS LIMITED financials: frequently asked questions

Answered from this company's own filed figures.

Yes. Okredo holds filed figures for XR THERAPEUTICS LIMITED covering 2022–2026, across 5 reported indicators. The most recent reported year is 2026.

XR THERAPEUTICS LIMITED reported net assets of £52.30K for 2026. That compares with £529.15K in 2025, a change of -90.12%.

XR THERAPEUTICS LIMITED reported total assets of £310.91K for 2026. That compares with £607.11K in 2025, a change of -48.79%.

XR THERAPEUTICS LIMITED reported cash in bank of £58.24K for 2026. That compares with £363.65K in 2025, a change of -83.98%.

XR THERAPEUTICS LIMITED reported 21 employees in 2026, compared with 18 in 2025.

Between 2024 and 2026, XR THERAPEUTICS LIMITED's net assets fell by 93.8%, cash in bank fell by 93.4%, total assets fell by 76.4% and total liabilities fell by 45.3%. Net assets contracted at 75.1% a year across the two years to 2026, from £845.39K to £52.30K. Reported headcount went from 11 in 2024 to 21 in 2026 (+10).

Okredo holds reported figures for the years 2022, 2023, 2024, 2025, 2026. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.